MMP2 and cancer: Overexpressed GSH in cancer can rapidly break the disulfide bond, and MMP-2 overexpressed in cancer can degrade the gelatin carrier, and through these two pathways, PTX can be released precisely and efficiently into the cancer lesion area (Zhou et al., 2020).